In a revolutionary stride that will change the landscape of cancer diagnostics in India, Dr. Lal PathLabs (DLPL) has become the first laboratory in the country to implement a deep learning based AI module for the identification of lymph node
Suneeta Reddy, the Managing Director of Apollo Hospitals Enterprise Ltd., has sold a 1.3% stake in the company for ?1,489 crore. The deal, handled through a block trade at ?7,850 per share with Morgan Stanley as the broker, was aimed at reducin...
Health Canada has licensed Ozempic (semaglutide injection) as the first-and-only drug to be used for once-weekly treatment of type 2 diabetes (T2D) and for the reduction of the risk of progression of kidney disease, end-stage kidney di...
A contract development and manufacturing agreement has been signed between AnGes Inc. and Boehringer Ingelheim, a biopharmaceutical business involved in both human and animal health, for the drug ingredient of AnGes' experimental treatment for
Gujarat Health Minister Shri Rushikesh Patel inaugurated the cutting-edge Varian TrueBeam 3.0 Radiotherapy system on Thursday at Apollo Hospitals
Dr. Anushtup De, Senior Consultant and Head - General & Minimally Invasive Surgery at Sarvodaya Hospital, Faridabad, explained that improvements in gallbladder surgery
On the occasion of World Senior Citizen’s Day 2025, P. D. Hinduja Hospital & Medical Research Centre today inaugurated its first-of-its-kind dedicated Geriatric Clinic committed to providing comprehensive care for senior citizens
The All India Organization of Chemists and Druggists (AIOCD) has ramped up its strategy to consolidate pharmaceutical distributors by forming the first Limited Liability Partnership (LLP) in Kerala.
Health Minister Damodar Rajanarsimha conducted a review of the performance of the Drugs Control Administration (DCA) and directed officials to initiate action under the PD Act against manufacturers of counterfeit medicines and banned medicines.
Manufacturers are being obliged to destroy stocks in order to comply with a new rule by the Central Drugs Standard Control Organization (CDSCO) that prohibits the export of pharmaceutical items with a shelf life of less than 60%